ASCO: Melanoma Tx Turns in 'Striking' Results

CHICAGO (MedPage Today) -- An investigational immune therapy, lambrolizumab, was safe and well tolerated in patients with advanced melanoma, a researcher reported here. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/06/asco-melanoma-tx-turns-in-results.html